In recent years, numerous reports have revealed that PD-L2 is elevated in many cancers, including ovarian cancer [11], lung adenocarcinoma [12], gastric cancer [13, 14], and esophageal squamous cell carcinoma [15]. This evidence concerns the gene PDCD1LG2 and ovarian carcinoma.